For years, the HPV vaccine has been the subject of controversy for its potential risks that include death. Now a new study reveals just how far Big Pharma will go to keep the truth away from the public.
According to a new study published in Clinical Rheumatology, the HPV vaccine contains a toxic adjuvant that may cause permanent disabilities.
Worse, a separate study found that 1 in 10 individuals who received the vaccine end up in the emergency room. The researchers criticized pharmaceutical companies as well as other health experts for concealing the dangers of the HPV vaccine.
A new study published in Clinical Rheumatology exposes how vaccine manufacturers used phony placebos in clinical trials to conceal a wide range of devastating risks associated with HPV vaccines. Instead of using genuine inert placebos and comparing health impacts over a number of years, as is required for most new drug approvals, Merck and GlaxoSmithKline spiked their placebos with a neurotoxic aluminum adjuvant and cut observation periods to a matter of months.
Researchers from Mexico’s National Institute of Cardiology pored over 28 studies published through January 2017—16 randomized trials and 12 post-marketing case series—pertaining to the three human papillomavirus (HPV) vaccines currently on the market globally. In their July 2017 peer-reviewed report, the authors, Manuel Martínez-Lavin and Luis Amezcua-Guerra, uncovered evidence of numerous adverse events, including life-threatening injuries, permanent disabilities, hospitalizations and deaths, reported after vaccination with GlaxoSmithKline’s bivalent Cervarix vaccine and Merck’s quadrivalent or nine-valent HPV vaccines (Gardasil and Gardasil 9). Pharmaceutical company scientists routinely dismissed, minimized or concealed those injuries using statistical gimmicks and invalid comparisons designed to diminish their relative significance.
Image courtesy of: Pan American Health Organization PAHO
